CONMED Corporation (CNMD)

Name: CONMED Corporation (CNMD) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: CONMED Corporation (CNMD)

Stock Card

$50.59

$0.11 (0.22%)

As on 27-Aug-2026 15:43EDT

Market cap

$1,530 Mln

Revenue (TTM)

$1,373 Mln

P/E Ratio

27.8

P/B Ratio

1.5

Div. Yield

0.4 %

CONMED (CNMD) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 49.92 High: 51.48

52 Week Range

Low: 31.44 High: 56.64

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

0.1 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

12.4
Debt to Equity

0.6
Book Value

$--
EPS

$1.8
Face value

--
Shares outstanding

29,951,248

10 Years Aggregate

CFO

$721.88 Mln

EBITDA

$890.61 Mln

Net Profit

$258.25 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
CONMED (CNMD)	24.6	18.5	40.3	-7.6	-22.3	-17.5	2.3
BSE Sensex	-9.1	1.1	1.2	-4.8	5.8	6.6	10.7
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 27-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
CONMED (CNMD)	-40.7	-37.3	23.5	-37.5	27.4	1.2	75.7
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
CONMED (CNMD)	50.6	1,529.6	1,372.6	56.5	8.2	5.4	27.8	1.5
10X Genomics Inc (TXG)	64.6	8,484.6	616.9	-75.1	1.7	-9.3	--	10.1
Avantor (AVTR)	14.6	9,638.1	6,561.1	-578.0	-4.5	-10.3	--	1.7
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.3
Bruker (BRKR)	59.4	9,074.5	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	181.5	10,905.5	612.8	-188.1	-30.6	-28.1	--	16.4
Lantheus Holdings (LNTH)	100.8	6,525.3	1,556.3	275.3	24.6	22.9	24	5.0
Merit Medical Systems (MMSI)	89.4	5,420.5	1,579.2	145.6	14.3	8.9	37.2	3.2
Penumbra (PEN)	321.7	12,752.7	1,504.9	160.6	13.6	10.9	79.4	8.4
Repligen (RGEN)	182.6	10,222.2	785.1	41.5	9.9	2	251.6	4.8

Shareholding Pattern

View Details

About CONMED (CNMD)

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation... System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida. Read more

Chairman of the Board, CEO & President

Mr. Curt R. Hartman
Executive VP, CFO & Principal Accounting Officer

Mr. Todd W. Garner CPA
Headquarters

Largo, FL
Website

https://www.conmed.com

FAQs for CONMED (CNMD)

What is the current share price of CONMED Corporation (CNMD) Today?

The share price of CONMED Corporation (CNMD) is $50.59 (NYSE) as of 27-Aug-2026 15:43 EDT. CONMED Corporation (CNMD) has given a return of -22.33% in the last 3 years.

What is the current PB & PE ratio of CONMED Corporation (CNMD)?

The P/E ratio of CONMED Corporation (CNMD) is 27.76 times as on 21-Aug-2026, a 38 discount to its peers’ median range of 44.46 times.
The P/B ratio of CONMED Corporation (CNMD) is 1.48 times as on 21-Aug-2026, a 61 discount to its peers’ median range of 3.84 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	26.77	1.22
2024	16.08	2.21
2023	53.52	4.14
2022	-34.02	3.68
2021	74.28	5.91

What is the 52 Week High and Low of CONMED Corporation (CNMD)?

The 52-week high and low of CONMED Corporation (CNMD) are Rs 56.64 and Rs 31.44 as of 28-Aug-2026.

What is the market cap of CONMED Corporation (CNMD)?

CONMED Corporation (CNMD) has a market capitalisation of $ 1,530 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in CONMED Corporation (CNMD)?

Before investing in CONMED Corporation (CNMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.